GRP
SCMP

Global Retirement Partners’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Global Retirement Partners’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-195
Closed -$4K – 1572
2017
Q4 		$4K Hold
195
– – ﹤0.01% 1195
2017
Q3 		$2K Hold
195
– – ﹤0.01% 1156
2017
Q2 		$2K Buy
+195
New +$1.99K ﹤0.01% 1088
2017
Q1 		– Sell
-195
Closed -$3K – 1170
2016
Q4 		$3K Buy
+195
New +$2.72K ﹤0.01% 938

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Global Retirement Partners's SCMP Position: Q1 2018 in Review

Global Retirement Partners sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 195 shares — an estimated $4K sold.

Global Retirement Partners first reported a position in SCMP in Q4 2016 and held it in 4 quarters. The position peaked at $4K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Global Retirement Partners reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Global Retirement Partners sold 195 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4K.
  • Global Retirement Partners first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 4 quarters.
  • Global Retirement Partners's Sucampo Pharmaceuticals, Inc. position peaked at $4K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Global Retirement Partners's 13F filing for Q1 2018, filed 10 Aug 2018.